On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 ...
I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet’s recent achievement in receiving Japan's Pharmaceutical and Medical Devices Agency (PMDA) approval for orthopedic ...
Medical Device Network on MSN
JPM26: Zimmer Biomet reveals plans for largest patient campaign in its history
The patient campaign is part of an effort to take Zimmer from being a company in ‘remediation mode’ and regain market share losses.
Add Yahoo as a preferred source to see more of our stories on Google. The system offers a simplified user interface Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results